In a sign of strong demand, Morgan Stanley's index subsidiary MSCI priced its offering of 14 million shares at $18, a 20% premium to its originally proposed $14-$16 range. MSCI is considered the pioneer of international equity indices and risk analytic tools. ...read more
MSCI, a spinoff of Morgan Stanley’s index products and analytics business, filed terms with the SEC Friday for its upcoming IPO. The company plans to offer 14 million shares at a price of $14 to $16 per share. The firm filed to list on the NYSE under the ticker ...read more
Worst weekly performers: Neutral Tandem, MSCI, Fuqi International
The following companies were the worst performing IPOs over the last five trading sessions: ...read more
ALERT: Worst weekly perfomers: ARYx Therapeutics, Whiting USA Trust I, MSCI
The following companies were the worst performing IPOs over the last five trading sessions: ...read more
Index pioneer MSCI prices 14mm shares at $18
In a sign of strong demand, Morgan Stanley's index subsidiary MSCI priced its offering of 14 million shares at $18, a 20% premium to its originally proposed $14-$16 range. MSCI is considered the pioneer of international equity indices and risk analytic tools. ...read more
Morgan Stanley's index and analytic tools provider MSCI announces terms
MSCI, a spinoff of Morgan Stanley’s index products and analytics business, filed terms with the SEC Friday for its upcoming IPO. The company plans to offer 14 million shares at a price of $14 to $16 per share. The firm filed to list on the NYSE under the ticker ...read more